Does the shingles vaccine Zostavax reverse the skin-specific T cell defect to varicella zoster challenge?
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Pharmacodynamics
- 11 Feb 2016 Accrual to date is 41% according to United Kingdom Clinical Research Network.
- 11 Feb 2016 Planned End Date changed from 10 Oct 2017 to 31 Jan 2017, according to United Kingdom Clinical Research Network.
- 27 Nov 2015 Planned End Date changed from 10 Oct 2015 to 10 Oct 2017.